13F filer · CIK 1422848 ↗
Capital Research Global Investors
You are looking at Q2 2024. See the latest, Q2 2026 →
Reported value
$455.74B
+3.1% on the quarter before
Positions
414
40 new · 36 sold out
Top 10
33.6%
of the value
Est. gain
−$5.59B
on stocks held all quarter
Est. return
−1.4%
on those stocks since Q1 2024
Positions as of Jun 30, 2024, from Capital Research Global Investors's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 51% of the reported value, each sized by its share, colored by what the fund did with it since Q1 2024. Striped tiles are options.
Largest buys
Since Q1 2024, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Nvidia~$8.31BAdded · 1.3% → 2.0%+67,302,388 shares
- Apple~$7.86BAdded · 1.2% → 3.2%+37,318,050 shares
- Salesforce~$2.52BAdded · 1.0% → 1.4%+9,783,674 shares
- Unitedhealth Group Inc~$2.25BAdded · 1.5% → 2.0%+4,414,540 shares
- Meta~$2.20BAdded · 3.8% → 4.3%+4,370,462 shares
- Boeing Co~$1.84BAdded · 0.7% → 1.1%+10,093,113 shares
- Oracle~$1.63BNew · 0.0% → 0.4%+11,571,987 shares
- Exxon Mobil Corp~$1.61BAdded · 0.5% → 0.8%+13,980,634 shares
- Cvs Health Corp~$1.32BAdded · 0.2% → 0.5%+22,311,687 shares
- Vertex Pharmaceuticals Inc~$1.31BAdded · 0.5% → 0.9%+2,795,457 shares
Largest sells
Since Q1 2024, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Broadcom~$10.29BCut · 5.2% → 3.9%−6,411,931 shares
- Abbott Labs~$2.78BCut · 2.2% → 1.3%−26,747,139 shares
- Ge Aerospace~$2.39BCut · 3.1% → 2.2%−15,046,597 shares
- Micron~$1.93BCut · 0.7% → 0.4%−14,648,141 shares
- Norwegian Cruise Line Hldg L~$1.19BSold out · 0.3% → 0.0%−57,048,312 shares
- Old Dominion Freight Line In~$1.15BCut · 0.3% → 0.0%−6,583,799 shares
- Corebridge Finl Inc~$972.3MSold out · 0.2% → 0.0%−33,841,160 shares
- Stryker Corporation~$902.2MCut · 0.8% → 0.5%−2,651,442 shares
- Airbnb~$875.7MCut · 0.4% → 0.2%−5,774,979 shares
- ServiceNow~$651.0MCut · 0.5% → 0.4%−827,555 shares
Holdings
As of Jun 30, 2024. Changes are in shares against Mar 31, 2024, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| MicrosoftCOM · shares −1.0% · price +6.2% | 7.6% | $34.61B | +$2.03B | ||||||||
| MetaCL A · shares +13% · price +3.8% | 4.3% | $19.65B | +$645.0M | ||||||||
| AmazonCOM · shares +6.6% · price +7.1% | 3.9% | $17.93B | +$1.12B | ||||||||
| BroadcomCOM · shares −37% · price +21.1% | 3.9% | $17.70B | +$3.09B | ||||||||
| AppleCOM · shares +117% · price +22.8% | 3.2% | $14.55B | +$1.24B | ||||||||
| AlphabetCAP STK CL A · shares +6.1% · price +20.7% | 2.5% | $11.17B | +$1.80B | ||||||||
| Ge AerospaceCOM NEW · shares −19% · price −9.4% | 2.2% | $10.13B | −$1.05B | ||||||||
| Rtx CorporationCOM · shares −2.9% · price +2.9% | 2.0% | $9.19B | +$261.7M | ||||||||
| NvidiaCOM · shares +1,037% · price −86.3% | 2.0% | $9.12B | −$5.06B | ||||||||
| Unitedhealth Group IncCOM · shares +34% · price +2.9% | 2.0% | $8.95B | +$191.4M | ||||||||
| Eli LillyCOM · shares +14% · price +16.4% | 1.8% | $8.26B | +$1.02B | ||||||||
| AlphabetCAP STK CL C · shares +14% · price +20.5% | 1.6% | $7.44B | +$1.11B | ||||||||
| Texas InstrumentsCOM · shares +13% · price +11.7% | 1.4% | $6.33B | +$583.5M | ||||||||
| SalesforceCOM · shares +68% · price −14.6% | 1.4% | $6.21B | −$633.8M | ||||||||
| Philip Morris Intl IncCOM · shares −0.6% · price +10.6% | 1.3% | $6.07B | +$581.5M | ||||||||
| Carrier GlobalCOM · shares +3.4% · price +8.5% | 1.3% | $6.02B | +$457.0M | ||||||||
| Abbott LabsCOM · shares −32% · price −8.6% | 1.3% | $5.95B | −$558.0M | ||||||||
| Abbvie IncCOM · shares +6.0% · price −5.8% | 1.2% | $5.69B | −$331.1M | ||||||||
| MastercardCL A · shares −6.6% · price −8.4% | 1.2% | $5.62B | −$515.0M | ||||||||
| Boeing CoCOM · shares +61% · price −5.7% | 1.1% | $4.83B | −$180.6M | ||||||||
| Royal Caribbean GroupCOM · shares +3.3% · price +14.7% | 1.1% | $4.83B | +$598.3M | ||||||||
| Thermo Fisher Scientific IncCOM · shares +1.5% · price −4.9% | 1.00% | $4.56B | −$228.9M | ||||||||
| GE HealthCareCOMMON STOCK · shares +0.3% · price −14.3% | 0.93% | $4.22B | −$701.4M | ||||||||
| Gilead Sciences IncCOM · shares −1.3% · price −6.3% | 0.91% | $4.15B | −$280.4M | ||||||||
| Home Depot IncCOM · shares −12% · price −10.3% | 0.89% | $4.07B | −$465.9M | ||||||||
| Total · 414 positions | 100% | $455.74B | −$5.59B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q1 2024 to Q2 2024: 374 stocks held throughout, down $5.59B (−1.4%).
- Broadcom+$3.09B+21%
- Microsoft+$2.03B+6%
- Alphabet+$1.80B+21%
- Apple+$1.24B+23%
- Amazon+$1.12B+7%
- Salesforce−$633.8M−15%
- GE HealthCare−$701.4M−14%
- Ge Aerospace−$1.05B−9%
- Canadian Nat Res Ltd−$3.20B−53%
- Nvidia−$5.06B−86%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 1 split read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 12, 2026 | $716.87B+11% | SEC ↗ |
| Q1 2026 | May 13, 2026 | $644.56B+19% | SEC ↗ |
| Q4 2025 | Feb 11, 2026 | $541.73B+2% | SEC ↗ |
| Q3 2025 | Nov 13, 2025 | $532.97B+7% | SEC ↗ |
| Q2 2025 | Aug 13, 2025 | $499.46B+9% | SEC ↗ |
| Q1 2025 | May 12, 2025 | $459.90B−5% | SEC ↗ |
| Q4 2024 | Feb 13, 2025 | $486.38B+1% | SEC ↗ |
| Q3 2024 | Nov 13, 2024 | $481.14B+6% | SEC ↗ |
| Q2 2024 | Aug 13, 2024 | $455.74B+3% | SEC ↗ |
| Q1 2024 | May 14, 2024 | $441.98B+9% | SEC ↗ |
| Q4 2023 | Feb 13, 2024 | $406.47B+12% | SEC ↗ |
| Q3 2023 | Nov 13, 2023 | $363.16B−3% | SEC ↗ |
| Q2 2023 | Aug 11, 2023 | $373.18B+7% | SEC ↗ |
| Q1 2023 | May 15, 2023 | $350.40B+6% | SEC ↗ |
| Q4 2022 | Feb 14, 2023 | $330.88B+9% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $304.37B−5% | SEC ↗ |
| Q2 2022 | Aug 15, 2022 | $321.05B−21% | SEC ↗ |
| Q1 2022 | May 19, 2022 (amended) | $405.10B−11% | SEC ↗ |
| Q4 2021 | Feb 14, 2022 | $452.67B+6% | SEC ↗ |
| Q3 2021 | Nov 15, 2021 | $428.65B−0% | SEC ↗ |
| Q2 2021 | Aug 16, 2021 | $429.52B+5% | SEC ↗ |
| Q1 2021 | May 14, 2021 | $408.71B+6% | SEC ↗ |
| Q4 2020 | Feb 12, 2021 | $385.30B+16% | SEC ↗ |
| Q3 2020 | Nov 13, 2020 | $333.11B+5% | SEC ↗ |
| Q2 2020 | Aug 14, 2020 | $316.13B+24% | SEC ↗ |
| Q1 2020 | May 15, 2020 | $254.90B−24% | SEC ↗ |
| Q4 2019 | Feb 18, 2020 | $333.48B+9% | SEC ↗ |
| Q3 2019 | Nov 14, 2019 | $304.85B−3% | SEC ↗ |
| Q2 2019 | Aug 14, 2019 | $314.99B−0% | SEC ↗ |
| Q1 2019 | May 15, 2019 | $315.45B+10% | SEC ↗ |
| Q4 2018 | Feb 14, 2019 | $287.02B−17% | SEC ↗ |
| Q3 2018 | Nov 14, 2018 | $344.02B−6% | SEC ↗ |
| Q2 2018 | Aug 14, 2018 | $366.12B+4% | SEC ↗ |
| Q1 2018 | May 15, 2018 | $351.43B+3% | SEC ↗ |
| Q4 2017 | Feb 14, 2018 | $340.76B+3% | SEC ↗ |
| Q3 2017 | Nov 14, 2017 | $331.24B+4% | SEC ↗ |
| Q2 2017 | Aug 14, 2017 | $319.49B+1% | SEC ↗ |
| Q1 2017 | May 15, 2017 | $317.04B+3% | SEC ↗ |
| Q4 2016 | Feb 15, 2017 | $308.47B+2% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $302.53B+3% | SEC ↗ |
| Q2 2016 | Aug 15, 2016 | $292.47B+1% | SEC ↗ |
| Q1 2016 | May 16, 2016 | $290.06B | SEC ↗ |